Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $50,952 - $98,643
-6,275 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $97,764 - $125,562
6,275 New
6,275 $135,000
Q4 2018

Feb 15, 2019

SELL
$14.59 - $23.84 $91,552 - $149,596
-6,275 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $16,848 - $20,520
800 Added 14.61%
6,275 $135,000
Q2 2018

Aug 15, 2018

SELL
$16.77 - $24.71 $33,540 - $49,420
-2,000 Reduced 26.76%
5,475 $133,000
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $8,340 - $11,035
-500 Reduced 6.27%
7,475 $123,000
Q4 2017

Feb 16, 2018

SELL
$11.23 - $19.1 $8,141 - $13,847
-725 Reduced 8.33%
7,975 $151,000
Q3 2017

Nov 16, 2017

BUY
$15.41 - $32.17 $134,067 - $279,879
8,700
8,700 $161,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.